公开(公告)号：US20190134140A1

公开(公告)日：2019-05-09

申请号：US15803608

申请日：2017-11-03

申请人： Lauranell Harrison BURCH

发明人： Lauranell Harrison BURCH

IPC分类号： A61K36/9066 ,  A61K9/00 ,  A61K31/12 ,  A61K31/05 ,  A61K36/70 ,  A61K31/352 ,  A61K36/23 ,  A61K36/489 ,  A61K31/4525 ,  A61K36/67 ,  A61K36/28 ,  A61K31/357 ,  A61K36/82 ,  A61K31/353 ,  A61K36/734 ,  A61K31/385 ,  A61K36/14 ,  A61K36/53 ,  A61K31/19 ,  A61K36/324 ,  A61K31/704 ,  A61K36/77

摘要： The invention relates to a new orally administered composition, which in present embodiments is a standardized phytochemical formulation but other embodiments may contain designed molecules. This formulation is capable of suppressing inflammation in a variety of disease conditions having an underlying inflammatory component, including but not limited to cystic fibrosis, COPD, asthma, and pancreatitis. It is an objective of the invention to provide a non-toxic therapy, which exhibits anti-oxidant anti-inflammatory properties without deleterious side effects.